a) Number weighted mean volume of AEII during postnatal development and in adults. There are no volume alterations before and at the end of bulk alveolarization. A significant increase was determined in adults compared to 3 and 7 days old pups. b) Size of AEII presented as V_S-ratioAEII during postnatal lung development into adulthood. Before and during bulk alveolarization there are no size changes. Adults show a significant increase compared to values before and at onset of alveolarization. c) Number weighted mean volume of AEII per lung volume during postnatal development and in adults. The highest values are seen before alveolarization. During alveolarization the quotient decreases and reaches significance compared to 3 days old pups at postnatal day 21.... by Julia Hüttmann (22656283)

“…During alveolarization the quotient decreases and reaches significance compared to 3 days old pups at postnatal day 21. …”

Baseline and post-treatment results of categorical electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Frequency distribution of SOLEC at baseline and follow-ups in WAD grade 2 and WAD grade 3. by Anneli Peolsson (7867601)

Subjects:

The CONSORT flow diagram. by Anneli Peolsson (7867601)

Subjects:

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the two groups WAD grades 2 and 3. by Anneli Peolsson (7867601)

Subjects:

Line graph showing the values of inflammatory cytokines at baseline and after treatment. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness. by Anneli Peolsson (7867601)

Subjects:

Baseline and Post-Treatment Myocardial Perfusion Defects Expressed as a Percentage of the Total Left Ventricular Surface Area in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline and post-treatment results of quantitative electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

CONSORT diagram illustrating patient flow during the study. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups. by Anneli Peolsson (7867601)

Subjects:

Outcomes in DHI score, dizziness and unsteadiness at baseline and at three- and 15-month follow-ups for each WAD group, and within-group effects. by Anneli Peolsson (7867601)

Subjects:

Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Illustrative images of the processing of a myocardial perfusion study in a patient with Chagas disease. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Clinical and Demographic Characteristics of the Study Population. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline descriptive characteristics of trial participants with dizziness, by treatment group. by Anneli Peolsson (7867601)

Subjects:

Illustrative images of the quantitative processing of polar maps from a myocardial perfusion study in one of the investigated patients. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the neck-specific exercise with internet support (NSEIT) group and t... by Anneli Peolsson (7867601)

Subjects:

Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

Subjects: